Analysis of Biological Activity of Sulfamide Derivatives as Antimicrobial Agents

Abstract

Sulfamides are significant compounds because of their biological effects on bacteria, fungi, and cancer. The antimicrobial and anticancer properties of sulfamide derivatives have been demonstrated in several microbial strains and cancer cell lines. They have worked mostly in the field of medicinal chemistry. Numerous microbiological pathogens are known to be resistant to the antibacterial effects of sulfamide derivatives. The most significant microorganisms in command of hospital-acquired nosocomial infections include Acinetobacter baumannii (A. baumannii), Methicillin-resistant Staphylococcus aureus (MRSA), Candida albicans (C. albicans), and Candida parapsilosis (C. parapsilosis). Multiple antibiotics can no longer treat these illnesses. Therefore, it is crucial to develop new antimicrobial agents. Three previously made compounds were tested for their antibacterial properties against these pathogens, including 3-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-1,1-dimethyl sulfamide (4) and 3-(7-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-1,1-dimethyl sulfamide (5). Using the disc diffusion method, antimicrobial activity was assessed, and values for the minimum inhibitory concentration (MIC) were calculated for zone formation seen in the tested pathogens. The results of the investigation demonstrated that sulfamide derivatives stopped the growth of bacteria against A. baumannii with zone widths of 7-9 mm, but had no impact on MRSA, C. albicans, and C. parapsilosis. Sulfamide derivatives' MIC values against A. baumannii were discovered to be 3.90 g/ml. These results provide us the ability to evaluate these sulfamide derivatives as potential new antibacterial therapies for A. baumannii.